Screening for Silent Atrial Fibrillation During Influenza Vaccination

UMC Utrecht

Status: Completed

Conditions: Atrial Fibrillation

Treatments: Device: 'MyDiagnostick

Study type: Interventional

Funder types: Other; Industry

Identifiers

NCT02006524

2013-85

Details and patient eligibility

About

Silent atrial fibrillation is an important cause of unnecessary strokes. If diagnosed and treated in time with anticoagulants, many disabling strokes can be prevented. In order to improve the diagnosis of atrial fibrillation the MyDiagnostick is developed; a user friendly and easy to use stick that diagnoses atrial fibrillation in one minute. During influenza vaccination, many patients who are also at risk for atrial fibrillation visit the general practice. This offers an ideal opportunity for screening for atrial fibrillation. The study investigates the yield of screening for atrial fibrillation with the MyDiagnostick during influenza vaccination (newly detected atrial fibrillation with corresponding CHA2DS2-Vasc score).

Enrollment: 3,269 patients

Sex: All

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Eligible for influenza vaccination

Exclusion criteria

• Not eligible for influenza vaccination

Trial design

Primary purpose: Diagnostic

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

3,269 participants in 1 patient group

Screening with MyDiagnostick

Active Comparator group

Description:

All patients eligible for influenza vaccination are screened for atrial fibrillation with the MyDiagnostick, an easy to use and patient friendly device.

Treatment:

Device: 'MyDiagnostick